Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform [Yahoo! Finance]
OSR Holdings, Inc. (OSRH)
Company Research
Source: Yahoo! Finance
cancer, today announced the appointment of Sébastien Wieckowski, PhD, as Chief Scientific Officer (CSO). This appointment strategically strengthens Vaximm's leadership with deep, long-standing expertise in the company's core technology. Dr. Wieckowski brings multidisciplinary experience spanning immunology and advanced data science, a profile uniquely poised to integrate reproducible analytical workflows and data-driven strategies to accelerate discovery and optimize platform performance. "I am excited to welcome Sébastien as CSO," said Dr. Andreas Niethammer, CEO of Vaximm. "Having worked closely with him since 2016, I have witnessed firsthand his deep scientific and technical mastery of our oral vector technology. His contributions to the overall program have been substantial, characterized by a rare combination of strategic vision and pragmatic execution. As we advance into later-stage clinical trials and begin integrating new assets, Sébastien's expertise will be vital in ensu
Show less
Read more
Impact Snapshot
Event Time:
OSRH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OSRH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OSRH alerts
High impacting OSR Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
OSRH
News
- Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial LaunchPR Newswire
- Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy PlatformPR Newswire
- Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in MilestonesPR Newswire
- Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings [Yahoo! Finance]Yahoo! Finance
- Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR HoldingsPR Newswire
OSRH
Sec Filings
- 1/27/26 - Form 8-K
- 1/14/26 - Form 8-K
- 11/25/25 - Form 8-K
- OSRH's page on the SEC website